60.43% of Aligos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aligos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Armistice Capital LLC	7,256,410	$2.54M	0.0%	+5.3%	9.290%
8/9/2024	Renaissance Technologies LLC	768,839	$0.27M	0.0%	-4.9%	0.984%
8/8/2024	Versant Venture Management LLC	1,457,937	$0.51M	0.7%	-37.2%	1.867%
8/6/2024	Acadian Asset Management LLC	829,485	$0.29M	0.0%	+26.1%	1.062%
5/29/2024	Opaleye Management Inc.	1,630,000	$1.60M	0.3%	+25.7%	2.087%
5/10/2024	Acadian Asset Management LLC	657,995	$0.64M	0.0%	+17.6%	0.870%
2/15/2024	Opaleye Management Inc.	1,297,000	$0.86M	0.2%	N/A	1.731%
2/14/2024	Hhlr Advisors LTD.	1,906,191	$1.27M	0.0%	-17.5%	2.544%
2/14/2024	Altitude Crest Partners Inc.	2,844,681	$1.89M	1.3%	N/A	3.796%
2/13/2024	Armistice Capital LLC	6,833,875	$4.54M	0.1%	N/A	9.120%
1/1/2024	Vanguard Group Inc.	1,010,617	$0.76M	0.0%	+1.6%	1.349%
11/14/2023	Newtyn Management LLC	920,000	$0.69M	0.2%	+2.2%	1.228%
5/15/2023	Logos Global Management LP	1,000,000	$0.87M	0.1%	N/A	2.329%
5/11/2023	Acadian Asset Management LLC	564,715	$0.49M	0.0%	+68.7%	1.315%
2/15/2023	Tang Capital Management LLC	2,816,391	$2.68M	0.4%	+68.2%	6.577%
2/10/2023	New York Life Investment Management LLC	263,832	$0.25M	0.0%	+12.7%	0.616%
11/15/2022	Tang Capital Management LLC	1,674,166	$1.84M	0.2%	+8.2%	3.910%
11/14/2022	Point72 Asset Management L.P.	917,036	$1.01M	0.0%	+14.6%	2.142%
11/14/2022	Ergoteles LLC	52,889	$58K	0.0%	-49.0%	0.124%
11/2/2022	Rockefeller Capital Management L.P.	77,499	$85K	0.0%	N/A	0.181%
8/15/2022	Pivotal bioVenture Partners Investment Advisor LLC	743,215	$0.90M	0.5%	-15.2%	1.736%
7/25/2022	Silverarc Capital Management LLC	58,392	$71K	0.0%	+447.8%	0.137%
7/18/2022	Brinker Capital Investments LLC	44,649	$54K	0.0%	N/A	0.105%
7/11/2022	Wedmont Private Capital	20,741	$25K	0.0%	N/A	0.049%
5/6/2022	IndexIQ Advisors LLC	192,976	$0.42M	0.0%	N/A	0.452%
4/19/2022	Denali Advisors LLC	16,000	$34K	0.0%	N/A	0.037%
2/14/2022	Virtus ETF Advisers LLC	14,209	$0.17M	0.1%	+108.5%	0.033%
2/14/2022	Point72 Asset Management L.P.	110,488	$1.31M	0.0%	+13.6%	0.259%
2/11/2022	Ensign Peak Advisors Inc	7,320	$87K	0.0%	N/A	0.017%
2/8/2022	Bank of America Corp DE	1,164,300	$13.82M	0.0%	+3,351.9%	2.733%
2/8/2022	ProShare Advisors LLC	10,177	$0.12M	0.0%	N/A	0.024%
2/8/2022	Northern Trust Corp	203,799	$2.42M	0.0%	+2.8%	0.478%
11/17/2021	Altium Capital Management LP	33,492	$0.52M	0.1%	N/A	0.079%
11/16/2021	Janus Henderson Group PLC	2,440,476	$37.66M	0.0%	+8.0%	5.728%
11/16/2021	Two Sigma Investments LP	89,863	$1.39M	0.0%	N/A	0.211%
11/16/2021	Wellington Management Group LLP	3,829,383	$59.39M	0.0%	-8.3%	8.987%
11/15/2021	Point72 Asset Management L.P.	97,300	$1.51M	0.0%	N/A	0.228%
11/15/2021	California State Teachers Retirement System	32,126	$0.50M	0.0%	+24.1%	0.075%
11/15/2021	Sphera Funds Management LTD.	249,197	$3.87M	0.3%	N/A	0.585%
11/12/2021	Renaissance Technologies LLC	53,200	$0.83M	0.0%	N/A	0.125%
11/12/2021	Jump Financial LLC	16,100	$0.25M	0.0%	N/A	0.038%
11/12/2021	Macquarie Group Ltd.	5,786	$90K	0.0%	N/A	0.014%
11/12/2021	The Manufacturers Life Insurance Company	12,276	$0.19M	0.0%	+10.8%	0.029%
11/12/2021	Credit Suisse AG	13,624	$0.21M	0.0%	N/A	0.032%
11/12/2021	Geode Capital Management LLC	313,655	$4.86M	0.0%	+22.8%	0.736%
11/10/2021	Goldman Sachs Group Inc.	23,737	$0.37M	0.0%	-37.5%	0.056%
11/10/2021	Citigroup Inc.	3,122	$48K	0.0%	+49.7%	0.007%
11/10/2021	O Shaughnessy Asset Management LLC	3,261	$51K	0.0%	N/A	0.008%
11/9/2021	BlackRock Inc.	1,239,562	$19.23M	0.0%	+14.3%	2.909%
11/8/2021	Swiss National Bank	56,200	$0.87M	0.0%	+67.3%	0.132%
11/5/2021	Advisor Group Holdings Inc.	4,500	$70K	0.0%	N/A	0.011%
11/4/2021	Deutsche Bank AG	83,752	$1.30M	0.0%	-13.2%	0.197%
11/1/2021	SG Americas Securities LLC	8,383	$0.13M	0.0%	N/A	0.020%
8/17/2021	Logos Global Management LP	212,785	$4.34M	0.4%	-55.3%	0.499%
8/17/2021	Metropolitan Life Insurance Co NY	6,361	$0.13M	0.0%	N/A	0.015%
8/17/2021	MetLife Investment Management LLC	8,308	$0.17M	0.0%	N/A	0.019%
8/17/2021	Price T Rowe Associates Inc. MD	27,230	$0.56M	0.0%	N/A	0.064%
8/17/2021	Acuta Capital Partners LLC	214,254	$4.37M	1.7%	N/A	0.503%
8/16/2021	California State Teachers Retirement System	25,890	$0.53M	0.0%	+61.3%	0.061%
8/16/2021	Charles Schwab Investment Management Inc.	89,039	$1.82M	0.0%	+24.4%	0.209%
8/16/2021	State Street Corp	298,587	$6.09M	0.0%	+73.5%	0.701%
8/16/2021	Nuveen Asset Management LLC	64,216	$1.31M	0.0%	+163.8%	0.151%
8/16/2021	Goldman Sachs Group Inc.	37,968	$0.77M	0.0%	-9.1%	0.089%
8/13/2021	HarbourVest Partners LLC	18,783	$0.38M	0.0%	N/A	0.049%
8/13/2021	Northern Trust Corp	178,014	$3.63M	0.0%	+56.6%	0.467%
8/13/2021	Geode Capital Management LLC	255,348	$5.21M	0.0%	+42.9%	0.669%
8/13/2021	Vanguard Group Inc.	983,296	$20.05M	0.0%	+59.9%	2.577%
8/12/2021	Versant Venture Management LLC	2,320,381	$47.30M	15.7%	-29.5%	6.082%
8/12/2021	State of Wisconsin Investment Board	20,725	$0.42M	0.0%	N/A	0.054%
8/12/2021	Legal & General Group Plc	2,647	$53K	0.0%	+153.3%	0.007%
8/12/2021	JPMorgan Chase & Co.	25,909	$0.53M	0.0%	-12.3%	0.068%
8/12/2021	The Manufacturers Life Insurance Company	11,084	$0.23M	0.0%	N/A	0.029%
8/11/2021	Bank of New York Mellon Corp	45,421	$0.93M	0.0%	+42.9%	0.119%
8/11/2021	BlackRock Inc.	1,084,044	$22.10M	0.0%	+55.8%	2.841%
8/11/2021	Deutsche Bank AG	96,491	$1.97M	0.0%	+6.6%	0.253%
8/10/2021	Virtus ETF Advisers LLC	7,167	$0.15M	0.1%	N/A	0.019%
8/10/2021	Citigroup Inc.	2,085	$43K	0.0%	+73.2%	0.005%
8/6/2021	Swiss National Bank	33,600	$0.69M	0.0%	N/A	0.088%
8/5/2021	Rhumbline Advisers	12,540	$0.26M	0.0%	N/A	0.033%
8/2/2021	New York State Common Retirement Fund	16,198	$0.33M	0.0%	+67.0%	0.042%
5/19/2021	Logos Global Management LP	476,547	$10.84M	1.1%	-21.4%	1.249%
5/18/2021	Millennium Management LLC	32,569	$0.74M	0.0%	N/A	0.085%
5/18/2021	Morgan Stanley	34,315	$0.78M	0.0%	+66.6%	0.090%
5/18/2021	California State Teachers Retirement System	16,049	$0.37M	0.0%	+5.1%	0.042%
5/17/2021	Janus Henderson Group PLC	2,230,051	$48.73M	0.0%	+17.7%	5.845%
5/17/2021	Nuveen Asset Management LLC	24,340	$0.55M	0.0%	+47.1%	0.064%
5/17/2021	Goldman Sachs Group Inc.	41,763	$0.95M	0.0%	N/A	0.109%
5/13/2021	Bank of New York Mellon Corp	31,777	$0.72M	0.0%	+5.5%	0.083%
5/13/2021	Citigroup Inc.	1,204	$27K	0.0%	-36.5%	0.003%
5/12/2021	Northern Trust Corp	113,640	$2.58M	0.0%	-4.8%	0.298%
5/12/2021	JPMorgan Chase & Co.	29,535	$0.67M	0.0%	-25.6%	0.077%
5/12/2021	UBS Group AG	3,630	$83K	0.0%	+118.3%	0.010%
5/11/2021	New York State Common Retirement Fund	9,700	$0.22M	0.0%	+70.2%	0.025%
5/7/2021	BlackRock Inc.	695,878	$15.82M	0.0%	+4.7%	1.824%
2/24/2021	Alyeska Investment Group L.P.	15,000	$0.42M	0.0%	N/A	0.039%
2/19/2021	JPMorgan Chase & Co.	39,684	$1.10M	0.0%	N/A	0.104%
2/16/2021	Alyeska Investment Group L.P.	15,000	$0.42M	0.0%	N/A	0.039%
2/16/2021	Baker BROS. Advisors LP	1,610,000	$44.52M	0.2%	N/A	4.224%
2/16/2021	Nuveen Asset Management LLC	16,550	$0.46M	0.0%	N/A	0.043%
2/16/2021	Davidson Kempner Capital Management LP	5,000	$0.14M	0.0%	N/A	0.013%

Data available starting January 2016

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). The company also develops ALG-000184, a capsid assembly modulator, which is completed Phase 1b clinical trial to treat chronic hepatitis B (CHB); and ALG-125755, a siRNA drug candidate, which is in Phase I clinical trial for the treatment of CHB. In addition, it develops ALG-097558, which is in Phase 2 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH; license agreement with Emory University to provide hepatitis B virus capsid assembly modulator technology; license agreement with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; and research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Today's Range

Now: $8.70

$8.52

$9.19

50 Day Range

MA: $12.62

$8.02

$19.43

52 Week Range

Now: $8.70

$7.35

$30.00

Volume

13,644 shs

Average Volume

29,123 shs

Market Capitalization

$679.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of Aligos Therapeutics?: Aligos Therapeutics' top insider shareholders include:
Carole Nuechterlein (Director)
Learn More about top insider investors at Aligos Therapeutics.

Biden to Launch “FedNOW” [Move Your Money Now]

From Priority Gold | Ad

Get your free information kit NOW, before it's too late.

ALGS Insider Trading

Aligos Therapeutics Insider Trading History Chart

Aligos Therapeutics Share Price & Price History

Aligos Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Aligos Therapeutics (NASDAQ:ALGS)